In a renewed effort to combat soaring healthcare costs and drug prices, the Federal Trade Commission (FTC) voted unanimously Thursday to increase scrutiny of pharmacy benefit managers, who act as middlemen between drug companies and consumers. The five-member commission, which includes two Republicans, voted to increase scrutiny of the discounts that pharmaceutical middlemen seek from… Continue reading FTC to Increase Scrutiny of Pharmacy Benefit Managers Over Rebates, Fees